Actively Recruiting

All Genders
ID05864638

Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study (OCIN-AIS-EVT REGISTRY)

Led by Changhai Hospital · Updated on 2025-01-27

10000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to observe and evaluate the outcomes of endovascular treatment for acute ischemic stroke (AIS) caused by vessel blockage in the brain's anterior or posterior circulation. The study is a prospective, multicenter, observational trial designed to assess the safety and functional recovery of patients receiving this treatment in routine clinical settings. Participants receive endovascular treatment, which may include mechanical thrombectomy using devices such as stents, aspiration catheters, or combinations with intra-arterial clot-dissolving therapies. The study records these procedures as part of standard care without randomization or comparison groups since it is observational. During the study, researchers will track patients' recovery and safety outcomes through various assessments, including a primary focus on functional improvement measured by the modified Rankin scale at 90 days. Additional measures include neurological status at 24 hours and 7 days, as well as details about blood vessel reopening immediately after and during the procedure. The study intends to provide insights into real-world treatment results and safety over the follow-up period.

CONDITIONS

Brief Title

Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Acute ischemic stroke caused by vessel blockage in anterior or posterior circulation confirmed by CTA, MRA, or DSA
  • Undergoing intravascular therapy with arterial access
  • Patient or legal representative has agreed to participate and signed informed consent
Not Eligible

You will not qualify if you...

  • No exclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Up to 1 day

Participants undergo endovascular treatment such as mechanical thrombectomy for acute ischemic stroke.

1 procedure visit

Monitoring

Duration - 90 days

Participants are monitored to assess functional outcomes and safety following the endovascular treatment.

Visits at 24 hours, 7 days, and 90 days post-procedure

Trial Site Locations

Total: 1 location

1

Jianimin Liu

Shanghai, China

Actively Recruiting

Loading map...

Research Team

P

Pengfei Yang, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Multicenter, Randomized, Double-blind, Placebo-controlled ...

Acute Ischemic Stroke

Actively Recruiting

1 location

A Multicenter, Randomized Controlled Clinical Investigation ...

Acute Ischemic Stroke

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here